Evaluating the Effectiveness of the Dissemination of Action Schools! BC
NCT01412203
Behavior, Body Weight
Vancouver, British Columbia, Canada
View Trial DetailsNCT Number: NCT03355729
The Quebec Family Study (QFS) is an observational study that was planned to investigate the role of genetic factors in physical fitness, body composition, risk factors for common disease and health-related behaviour.
Looking for future studies?
Notify Me10 year and older
All sexes
Observational
The Quebec Family Study was an observational study with three cycles of data collection between 1978 and 1992. During the first cycle of data collection (Phase 1: 1978-1982), a total of 1,650 subjects from 375 families were recruited. During the second cycle (Phase 2: 1989-1997), 385 subjects from 105 phase 1 families were retested and an additional 372 subject from 74 families were recruited. During the third cycle (Phase 3: 1998-2002), 204 subjects from phase 1 were tested a third time, 113 subjects from phase 2 were tested a second time and 194 new subjects from 44 families were recruited.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Through study completion, an average of 24 years
Body composition as assessed by underwater weighing
Time frame: Through study completion, an average of 24 years
Body mass index assessed from height and weight
Time frame: Through study completion, an average of 24 years
Abdominal fat as assessed by commuted tomography
Time frame: Through study completion, an average of 24 years
Waist and hip circumferences (cm)
Time frame: Through study completion, an average of 24 years
Total caloric intake and macronutrient intake using a 3-day dietary record
Time frame: Through study completion, an average of 24 years
Eating behaviour assessed using the Three-Factor Eating questionnaire
Time frame: Through study completion, an average of 24 years
Oxygen consumption at rest and during exercise
Time frame: Through study completion, an average of 24 years
Physical activity level assessed by questionnaire
Time frame: Through study completion, an average of 24 years
Systolic and diastolic blood pressure
Time frame: Through study completion, an average of 24 years
Fasting levels of triglycerides, LDL-cholesterol and HDL-cholesterol in mmo/L
Time frame: Through study completion, an average of 24 years
Plasma glucose levels in a fasting state and following an oral glucose tolerance test, inflammatory markers.
Plasma glucose levels in a fasting state and during an oral glucose tolerance test
Time frame: Through study completion, an average of 24 years
Plasma insulin levels in a fasting state and following an oral glucose tolerance test.
Time frame: Through study completion, an average of 24 years
C-reactive protein (CRP in mg/ml)
Time frame: Through study completion, an average of 24 years
Adiponectin levels (in micrograms/ml)
Time frame: Through study completion, an average of 24 years
Interleukin-6 (IL6) and tumor necrosis factor-alpha (TNF-alpha) in pg/ml
Time frame: Through study completion, an average of 24 years
Smoking habits (nb of cigarettes per day)
Time frame: Through study completion, an average of 24 years
Sleeping (hours/day)
Time frame: Through study completion, an average of 24 years
Alcohol consumption (nb of drinks per week)
Louis Pérusse
Other
The Quebec Family Study: an Observational Study Aimed at Investigating the Role of Genetic Factors in Physical Fitness, Obesity and Risk Factors for Common Diseases and Health-related Behaviours
Acronym: QFS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01412203
Behavior, Body Weight
Vancouver, British Columbia, Canada
View Trial DetailsNCT03768245
Behavior, Body Weight
Mexico City, Mexico
View Trial DetailsNCT03182621
Body Weight, Cognitive Function 1, Social
View Trial DetailsNCT05394363
Allergy and Immunology, Behavior
Parkville, Victoria, Australia
View Trial Details